While the dollar volume is not large relative to market cap, the coordinated selling by the CEO, CMO, and other executives raises caution, especially ahead of potential catalysts. Monitor upcoming earnings or clinical trial updates for confirmation of business momentum. Consider this a warning sign if no positive news follows.
Price Chart
Executive Summary
Four corporate insiders at Pharvaris N.V. (PHVS) sold shares in a concentrated 7-day window, including CEO Berndt Modig who sold $66K worth of stock. The total open-market sales amount to approximately $219,000, with additional non-cash derivative exercises that do not represent economic dispositions. This represents a modest but notable insider selling cluster involving key C-suite executives.
Key Financial Metrics
Key Facts
- CEO Berndt Modig sold 2,300 shares for $66,000 on April 16, 2026, at $28.60 per share.
- Chief Medical Officer Lu Peng sold 7,101 shares across two transactions totaling $213,405 (including $210,402 on April 22 and $3,003 on April 23).
- Chief Early Development Anne Lesage sold 600 shares for $18,003 across two dates (April 22 and 23).
- Director Schikan sold 7,100 shares for $213,382 (April 22 and 23).
- Total open-market sales by insiders: ~$429,000 over 7 days.
- Multiple non-cash derivative exercises occurred (transaction codes A, M, F), totaling $0 in economic value.
- Cluster involves three C-suite executives and one director, increasing signal relevance.
Financial Impact
$429,000 in total open-market insider sales over 7 days, representing ~0.024% of $1.8B market cap — modest in scale but notable due to participation by top executives.
Risk Factors
- Insider selling may signal reduced confidence in near-term valuation or upcoming headwinds.
- Non-cash derivative exercises could indicate routine option expirations rather than strategic economic decisions, but open-market sales are more meaningful.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PHVS-1777054200768 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $38.06 $36.37 | ▲ +4.44% | ▲ +5.26% | $31.07 (+18.38%) |
Sep 14, 2026 17d ago | 144 | $38.06 $35.20 | ▼ −7.51% | ▼ −9.63% | $31.07 (−18.38%) |
Sep 14, 2026 18d ago | Insider Cluster | $38.86 $36.02 | ▼ −7.31% | ▼ −7.41% | $31.07 (−20.06%) |
Sep 11, 2026 21d ago | Insider Cluster | $38.02 $36.37 | ▼ −4.34% | ▼ −4.12% | $31.07 (−18.29%) |
Sep 8, 2026 24d ago | 6-K | $37.84 $38.86 | ▲ +2.70% | ▲ +3.36% | $31.07 (−17.90%) |
Aug 12, 2026 7w ago | 6-K | $36.46 $36.27 | ▼ −0.52% | ▼ −0.08% | $31.07 (−14.80%) |
Aug 12, 2026 7w ago | Press Release | $36.46 $36.27 | ▼ −0.52% | ▼ −0.08% | $31.07 (−14.80%) |
Aug 6, 2026 8w ago | Press Release | $34.45 $34.04 | ▼ −1.19% | ▼ −2.40% | $31.07 (−9.83%) |
Jul 6, 2026 12w ago | Press Release | $33.22 $35.07 | ▲ +5.57% | ▲ +5.08% | $31.07 (−6.49%) |
Jul 1, 2026 13w ago | Insider Cluster | $33.86 $35.96 | ▲ +6.20% | ▲ +5.27% | $31.07 (−8.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access